Home-based diphenylcyclopropenone immunotherapy for alopecia areata: A large retrospective study of 94 cases

J Dermatol. 2023 Aug;50(8):1093-1095. doi: 10.1111/1346-8138.16863. Epub 2023 Jun 19.

Authors

Kyung-Hwa Nam^{1

2}, Geon-Jong Lee¹, Joo-Ik Kim¹, Ki-Hun Song¹, Jin Park^{1

2}

Affiliations

¹ Department of Dermatology, Jeonbuk National University Medical School, Jeonju, South Korea.
² Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, South Korea.

PMID: 37334761
DOI: 10.1111/1346-8138.16863

No abstract available

Keywords: alopecia areata; immunotherapy; quality of life; safety; treatment outcome.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Alopecia Areata* / drug therapy
Cyclopropanes / therapeutic use
Humans
Immunotherapy
Retrospective Studies

Substances

diphenylcyclopropenone
Cyclopropanes

Supplementary concepts

Diffuse alopecia